Viking Global Investors Lp Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

VIKING GLOBAL INVESTORS LP Transaction History

Date	Transaction	Value	Shares Traded	Form
Dec 01 2020	SELL Open market or private sale	$25,250,000 $50.5 p/Share	500,000
Apr 07 2020	BUY Open market or private purchase	$13,050,000 $18.0 p/Share	725,000

Also insider at

Wayfair Inc. Consumer Cyclical

> 10% Shareholder

EDIT

Editas Medicine, Inc. Healthcare

> 10% Shareholder

FDC

FIRST DATA CORP

> 10% Shareholder

ABUS

Arbutus Biopharma Corp Healthcare

> 10% Shareholder

MYOV

Myovant Sciences Ltd. Healthcare

> 10% Shareholder

SIOX

Sio Gene Therapies Inc. Healthcare

> 10% Shareholder

UROV

Urovant Sciences Ltd.

> 10% Shareholder

BBIO

BridgeBio Pharma, Inc. Healthcare

ADPT

Adaptive Biotechnologies Corp Healthcare

> 10% Shareholder

DNA

Ginkgo Bioworks Holdings, Inc. Healthcare

INBX

Inhibrx, Inc. Healthcare

FDMT

4D Molecular Therapeutics, Inc. Healthcare

RLYB

Rallybio Corp Healthcare

FIGS

FIGS, Inc. Consumer Cyclical

> 10% Shareholder

PRCT

PROCEPT BioRobotics Corp Healthcare

APG

APi Group Corp Industrials

AMLX

Amylyx Pharmaceuticals, Inc. Healthcare

RYZB

RayzeBio, Inc.

FLAC

Frazier Lifesciences Acquisition Corp Financial Services

ROIV

Roivant Sciences Ltd. Healthcare

VGI